GABAPENTIN (GABAPENTIN) — FDA Approval ANDA211330 (PAI HOLDINGS PHARM)
GABAPENTIN (GABAPENTIN) — FDA Approval ANDA211330 (PAI HOLDINGS PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: GABAPENTIN; Active ingredients: GABAPENTIN; Application number: ANDA211330.
| Brand name | GABAPENTIN |
|---|---|
| Active ingredients | GABAPENTIN |
| Application number | ANDA211330 |
| Sponsor | PAI HOLDINGS PHARM |
| Dosage form | SOLUTION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20191203 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →